---
title: "Pearl: A Foundation Model for Placing Every Atom in the Right Location"
date: 2026-02-24 13:50:00 +0900
description: "Genesis Molecular AIì˜ Pearlì€ ëŒ€ê·œëª¨ synthetic data, SO(3)-equivariant diffusion module, multi-chain templatingì„ í†µí•´ protein-ligand cofoldingì—ì„œ AlphaFold 3ë¥¼ 14.5% ìƒëŒ€ ê°œì„ ìœ¼ë¡œ ëŠ¥ê°€í•˜ëŠ” SOTAë¥¼ ë‹¬ì„±í•œë‹¤."
categories: [Paper Review, Drug Discovery]
tags: [protein-ligand, cofolding, drug-discovery, diffusion, equivariant, alphafold3, pearl, synthetic-data, structure-prediction]
math: true
mermaid: true
image:
  path: /assets/img/posts/pearl-foundation-model-placing-every-atom/fig1_overview.png
  alt: "Pearlì˜ overview: ì•„í‚¤í…ì²˜, í•™ìŠµ ë°ì´í„°, inference flowì™€ ë²¤ì¹˜ë§ˆí¬ ê²°ê³¼"
---

Protein-ligand cofolding â€” ë‹¨ë°±ì§ˆê³¼ ì•½ë¬¼ í›„ë³´ ë¶„ìì˜ 3D ê²°í•© êµ¬ì¡°ë¥¼ ë™ì‹œì— ì˜ˆì¸¡í•˜ëŠ” ë¬¸ì œ â€” ì€ computational drug discoveryì˜ í•µì‹¬ì´ë‹¤. AlphaFold 3ê°€ ì´ ë¶„ì•¼ì˜ íŒ¨ëŸ¬ë‹¤ì„ì„ ì—° ì´í›„, ìˆ˜ë§ì€ í›„ì† ëª¨ë¸(Boltz-1, Chai-1, Protenix)ì´ ë“±ì¥í–ˆì§€ë§Œ, **ì‹¤ì œ ì•½ë¬¼ ì„¤ê³„ì— í•„ìš”í•œ ìˆ˜ì¤€ì˜ ì •í™•ë„ì™€ ë¬¼ë¦¬ì  íƒ€ë‹¹ì„±**ì—ëŠ” ì—¬ì „íˆ ë¯¸ì¹˜ì§€ ëª»í•œë‹¤.

Genesis Molecular AIì™€ NVIDIAì˜ Pearlì€ ì´ ë¬¸ì œì— ì„¸ ê°€ì§€ ì¶•ìœ¼ë¡œ ì ‘ê·¼í•œë‹¤: (1) **ëŒ€ê·œëª¨ synthetic data** â€” PDBì˜ 147ë°° ê·œëª¨ê°€ ì•„ë‹Œ physics-based ë°©ë²•ìœ¼ë¡œ ìƒì„±í•œ ë‹¤ì–‘í•œ í•©ì„± ë³µí•©ì²´, (2) **SO(3)-equivariant diffusion module** â€” íšŒì „ ëŒ€ì¹­ì„ ì•„í‚¤í…ì²˜ ìˆ˜ì¤€ì—ì„œ ê°•ì œ, (3) **multi-chain templating** â€” ì¶”ë¡  ì‹œ ê¸°ì¡´ êµ¬ì¡° ì •ë³´ë¥¼ í™œìš©í•œ controllable generation.

ê²°ê³¼ëŠ” ì¸ìƒì ì´ë‹¤: Runs N' Poses ë²¤ì¹˜ë§ˆí¬ì—ì„œ **RMSD < 2Ã… & PB-valid ê¸°ì¤€ 85.2%** ì„±ê³µë¥ ë¡œ AlphaFold 3(74.4%)ë¥¼ **14.5% ìƒëŒ€ ê°œì„ **. ë” ì—„ê²©í•œ RMSD < 1Ã…ì—ì„œëŠ” ê²©ì°¨ê°€ ë” ë²Œì–´ì§„ë‹¤.

## Problem: Cofoldingì˜ ì„¸ ê°€ì§€ ë²½

í˜„ì¬ protein-ligand cofolding ëª¨ë¸ì´ ì§ë©´í•œ ê·¼ë³¸ì  ë¬¸ì œ:

1. **ë°ì´í„° ë¶€ì¡±ê³¼ í¸í–¥**: PDBëŠ” í…ìŠ¤íŠ¸/ì´ë¯¸ì§€ ë„ë©”ì¸ì— ë¹„í•´ orders of magnitude ì ì€ ë°ì´í„°ë¥¼ ê°€ì§€ê³  ìˆìœ¼ë©°, íŠ¹ì • íƒ€ê²Ÿ/í™”í•™í˜•ì— í¸í–¥ë˜ì–´ ìˆë‹¤. ëª¨ë¸ì´ ì¼ë°˜í™”í•˜ì§€ ëª»í•˜ê³  í•™ìŠµ ë°ì´í„°ë¥¼ **ì•”ê¸°(memorization)**í•˜ëŠ” í˜„ìƒì´ ë³´ê³ ëœë‹¤.

2. **ë¬¼ë¦¬ì  íƒ€ë‹¹ì„± ë¶€ì¬**: ê¸°ì¡´ ëª¨ë¸ì´ ìƒì„±í•œ í¬ì¦ˆê°€ í‘œë©´ì ìœ¼ë¡œ ê·¸ëŸ´ë“¯í•´ ë³´ì´ì§€ë§Œ ligand strain, shape complementarity, non-covalent interaction ë“±ì˜ ë¬¼ë¦¬ì  ìš”ê±´ì„ ìœ„ë°˜í•˜ëŠ” "hallucination"ì´ ë¹ˆë²ˆí•˜ë‹¤.

3. **ì œí•œëœ controllability**: ì‹¤ì œ drug discoveryì—ì„œëŠ” homologous êµ¬ì¡°, ì•Œë ¤ì§„ binding pocket ë“±ì˜ ë³´ì¡° ì •ë³´ê°€ ìˆëŠ” ê²½ìš°ê°€ ë§ì§€ë§Œ, ê¸°ì¡´ ëª¨ë¸ì€ ì´ë¥¼ í™œìš©í•  ìˆ˜ ìˆëŠ” ìœ ì—°í•œ ë©”ì»¤ë‹ˆì¦˜ì´ ë¶€ì¡±í•˜ë‹¤.

> Pearlì€ ì´ ì„¸ ê°€ì§€ ë¬¸ì œë¥¼ ê°ê° synthetic data, equivariant architecture, multi-chain templatingìœ¼ë¡œ í•´ê²°í•œë‹¤.
{: .prompt-tip }

## Key Idea: Data + Equivariance + Controllability

Pearlì˜ í•µì‹¬ì„ í•œ ë¬¸ì¥ìœ¼ë¡œ ìš”ì•½í•˜ë©´: **synthetic dataë¡œ ë°ì´í„° ë¶€ì¡±ì„ ê·¹ë³µí•˜ê³ , SO(3)-equivariant diffusionìœ¼ë¡œ ë¬¼ë¦¬ì  ëŒ€ì¹­ì„ ê°•ì œí•˜ë©°, multi-chain templateìœ¼ë¡œ inference-time controllabilityë¥¼ ì œê³µí•œë‹¤.**

ê¸°ì¡´ cofolding ëª¨ë¸ê³¼ì˜ í•µì‹¬ ì°¨ì´:

| | AF3/Boltz/Chai | Pearl |
|---|---|---|
| Structure Module | ë²”ìš© Transformer (ë¹„ë“±ë³€) | **SO(3)-equivariant Transformer** |
| í•™ìŠµ ë°ì´í„° | PDB + monomer distillation | PDB + monomer distillation + **synthetic PL complexes** |
| Template | Protein-only | **Multi-chain (protein + ligand + cofactor)** |
| Controllability | ì œí•œì  | Unconditional + **Conditional cofolding + Guidance** |

## How it works

### Overview

Pearlì˜ ì „ì²´ íŒŒì´í”„ë¼ì¸ì€ í¬ê²Œ ë‘ ë‹¨ê³„ë¡œ ë‚˜ë‰œë‹¤: (1) íšŒì „/ë³‘ì§„ ë¶ˆë³€ì¸ **Trunk**ì´ pairwise representationì„ í•™ìŠµí•˜ê³ , (2) **SO(3)-equivariant Diffusion Module**ì´ ì´ë¥¼ conditioningìœ¼ë¡œ ë°›ì•„ 3D ì¢Œí‘œë¥¼ ìƒì„±í•œë‹¤.

![Pearl Overview](/assets/img/posts/pearl-foundation-model-placing-every-atom/fig1_overview.png)
_Figure 1: Pearl ê°œìš”. (a) SARS-CoV-2 ì˜ˆì¸¡ ì˜ˆì‹œ. (b) Unconditional cofolding ê²°ê³¼. (c) Pocket-conditional cofolding ê²°ê³¼. (d) Training/inference flow. ì¶œì²˜: ì› ë…¼ë¬¸_

```mermaid
graph TD
    subgraph Input
        SEQ["ğŸ§¬ Protein Sequence<br/>+ Ligand Topology"]
        MSA["MSA / Templates"]
        SYNTH["Synthetic Data<br/>(Physics-based)"]
    end
    
    subgraph Trunk["Trunk (Invariant)"]
        TRIMUL["Lightweight<br/>Triangle Multiplication"]
        PAIR["Pairwise<br/>Representation"]
        TRIMUL --> PAIR
    end
    
    subgraph Diffusion["SO(3)-Equivariant Diffusion Module"]
        EQT["Equivariant<br/>Transformer Blocks"]
        EQFF["Equivariant<br/>Feed-Forward"]
        EQT --> EQFF
    end
    
    subgraph Inference["Inference Modes"]
        UNCOND["Unconditional<br/>Cofolding"]
        COND["Pocket-Conditional<br/>Cofolding"]
        GUIDE["Guidance &<br/>Steering"]
    end
    
    SEQ --> Trunk
    MSA --> Trunk
    Trunk -->|"Pair repr.<br/>(amortized)"| Diffusion
    Diffusion --> UNCOND
    Diffusion --> COND
    Diffusion --> GUIDE
    SYNTH -.->|Training| Trunk
    SYNTH -.->|Training| Diffusion
    
    style Diffusion fill:#e8f5e9
    style SYNTH fill:#fff3e0
    style COND fill:#e1f5fe
```

Trunkì˜ ê³„ì‚° ë¹„ìš©ì´ ë¹„ì‹¼ pairwise representationì€ í•œ ë²ˆë§Œ ê³„ì‚°ë˜ê³ , diffusion moduleì˜ ì—¬ëŸ¬ denoising stepì—ì„œ **amortize**ë˜ì–´ ì¬ì‚¬ìš©ëœë‹¤. ì´ëŠ” AF3ì™€ ìœ ì‚¬í•œ ì„¤ê³„ì§€ë§Œ, diffusion module ìì²´ê°€ equivariantí•˜ë‹¤ëŠ” ì ì´ ë‹¤ë¥´ë‹¤.

### Core Architecture: SO(3)-Equivariant Diffusion Module

Pearlì˜ ì•„í‚¤í…ì²˜ì  í•µì‹¬ì€ **SO(3)-equivariant diffusion module**ì´ë‹¤. ê¸°ì¡´ cofolding ëª¨ë¸(AF3, Boltz-1, Chai-1)ì˜ structure moduleì€ ë²”ìš© Transformerì¸ë°, Pearlì€ ì—¬ê¸°ì— **equivariant transformer (EqT) ë¸”ë¡**ì„ ì‚¬ìš©í•œë‹¤.

![Equivariant Architecture](/assets/img/posts/pearl-foundation-model-placing-every-atom/fig2_equivariant_architecture.png)
_Figure 2: Equivariant diffusion moduleì˜ í•µì‹¬ ì»´í¬ë„ŒíŠ¸. (ì¢Œ) Equivariant self-attention â€” scalar/vector ì…ë ¥ì„ ë¶„ë¦¬í•˜ì—¬ Q/Kë¥¼ êµ¬ì„±. (ìš°) Equivariant feed-forward â€” vectorì— ëŒ€í•´ gated nonlinearity ì ìš©. ì¶œì²˜: ì› ë…¼ë¬¸_

EqT ë¸”ë¡ì€ **scalar feature**ì™€ **vector feature**ë¥¼ ë¶„ë¦¬í•˜ì—¬ ì²˜ë¦¬í•œë‹¤:

- **Scalar (ë¶ˆë³€)**: í‘œì¤€ attentionê³¼ ìœ ì‚¬í•˜ê²Œ ì²˜ë¦¬
- **Vector (ë“±ë³€)**: 3D ë°©í–¥ ì •ë³´ë¥¼ ë³´ì¡´í•˜ë©°, rotationì— ëŒ€í•´ equivariantí•˜ê²Œ ë³€í™˜

Vector ì„±ë¶„ì— ë¹„ì„ í˜•ì„±ì„ ì ìš©í•˜ê¸° ìœ„í•´ **gated nonlinearity**ë¥¼ ì‚¬ìš©í•œë‹¤: scalar ì„±ë¶„ì´ gate ì—­í• ì„ í•˜ì—¬ vector ì„±ë¶„ì˜ í¬ê¸°ë¥¼ ì¡°ì ˆí•˜ë˜, ë°©í–¥ì€ ë³´ì¡´í•œë‹¤.

<details>
<summary>ğŸ“ Equivariant Transformer Block Pseudocode (í´ë¦­í•˜ì—¬ í¼ì¹˜ê¸°)</summary>

```python
class EquivariantTransformerBlock(nn.Module):
    """
    SO(3)-equivariant transformer block for Pearl's diffusion module.
    Processes scalar (invariant) and vector (equivariant) features separately.
    """
    
    def __init__(self, d_scalar, d_vector, n_heads):
        super().__init__()
        self.n_heads = n_heads
        
        # Scalar Q/K/V projections
        self.scalar_qkv = nn.Linear(d_scalar, 3 * d_scalar)
        
        # Vector Q/K projections (no V â€” vectors mixed differently)
        self.vector_qk = nn.Linear(d_vector, 2 * d_vector)
        
        # Pair representation â†’ attention bias
        self.pair_bias = nn.Linear(d_pair, n_heads)
        
        # Equivariant feed-forward (gated nonlinearity for vectors)
        self.scalar_ff = nn.Sequential(
            nn.Linear(d_scalar, 4 * d_scalar),
            nn.SiLU(),
            nn.Linear(4 * d_scalar, d_scalar),
        )
        self.vector_linear = nn.Linear(d_vector, d_vector)
        self.vector_gate = nn.Linear(d_scalar, d_vector)  # scalar â†’ gate
    
    def forward(self, s, v, pair_repr):
        """
        s: (B, N, d_scalar)  â€” scalar (invariant) features
        v: (B, N, d_vector, 3) â€” vector (equivariant) features
        pair_repr: (B, N, N, d_pair) â€” pairwise representation from trunk
        """
        # === Equivariant Self-Attention ===
        # Scalar attention
        q_s, k_s, v_s = self.scalar_qkv(s).chunk(3, dim=-1)
        
        # Vector Q/K (dot products are invariant â†’ can compute attention weights)
        q_v, k_v = self.vector_qk(v).chunk(2, dim=-2)
        
        # Attention weights: scalar dot product + vector dot product + pair bias
        # All three terms are SO(3)-invariant
        attn = (
            einsum(q_s, k_s, "b i d, b j d -> b i j")
            + einsum(q_v, k_v, "b i d c, b j d c -> b i j")  # vector dot prod
            + self.pair_bias(pair_repr).squeeze(-1)            # pair bias
        ) / math.sqrt(q_s.shape[-1])
        
        attn = F.softmax(attn, dim=-1)
        
        # Update scalar
        s_out = einsum(attn, v_s, "b i j, b j d -> b i d")
        
        # Update vector (equivariant: weighted sum of vectors)
        v_out = einsum(attn, v, "b i j, b j d c -> b i d c")
        
        s = s + s_out
        v = v + v_out
        
        # === Equivariant Feed-Forward ===
        # Scalar: standard FFN
        s = s + self.scalar_ff(s)
        
        # Vector: gated nonlinearity (scalar gates vector magnitude)
        gate = torch.sigmoid(self.vector_gate(s))  # (B, N, d_vector)
        v_linear = self.vector_linear(v)             # (B, N, d_vector, 3)
        v = v + gate.unsqueeze(-1) * v_linear        # gate preserves direction
        
        return s, v
```

</details>

**ì™œ equivarianceê°€ ì¤‘ìš”í•œê°€?**

- **Sample efficiency**: íšŒì „ ëŒ€ì¹­ì„ ì•„í‚¤í…ì²˜ê°€ ë³´ì¥í•˜ë©´, data augmentationë§Œìœ¼ë¡œ equivarianceë¥¼ í•™ìŠµí•´ì•¼ í•˜ëŠ” ê²ƒë³´ë‹¤ í›¨ì”¬ ì ì€ ë°ì´í„°ë¡œ ê°™ì€ ì„±ëŠ¥ì— ë„ë‹¬
- **ë¬¼ë¦¬ì  íƒ€ë‹¹ì„±**: ê²°ê³¼ êµ¬ì¡°ê°€ ì…ë ¥ì˜ ì„ì˜ íšŒì „ì— ëŒ€í•´ ìë™ìœ¼ë¡œ ì¼ê´€ëœ ì˜ˆì¸¡ì„ ìƒì„± â€” hallucination ê°ì†Œ

Pearlì€ data augmentationê³¼ equivariant architectureë¥¼ **í•¨ê»˜** ì‚¬ìš©í•˜ì—¬ ì‹œë„ˆì§€ë¥¼ ì–»ëŠ”ë‹¤.

### Key Innovation: Large-Scale Synthetic Data

Pearlì˜ ê°€ì¥ ë…íŠ¹í•œ ê¸°ì—¬ëŠ” **physics-based ë°©ë²•ìœ¼ë¡œ ìƒì„±í•œ ëŒ€ê·œëª¨ í•©ì„± protein-ligand ë³µí•©ì²´ ë°ì´í„°ì…‹**ì´ë‹¤. [SeedFold](/posts/seedfold-scaling-biomolecular-structure-prediction/)ë‚˜ SimpleFoldê°€ ë‹¤ë¥¸ AI ëª¨ë¸(AlphaFold2)ë¡œë¶€í„° distillationí•œ ê²ƒê³¼ ë‹¤ë¥´ê²Œ, Pearlì€ physics-based docking/samplingìœ¼ë¡œ ìƒˆë¡œìš´ ligand-pocket ì¡°í•©ì„ ìƒì„±í•œë‹¤.

![Synthetic Data Scaling](/assets/img/posts/pearl-foundation-model-placing-every-atom/fig6_synthetic_data_scaling.png)
_Figure 6: Synthetic data ë¹„ìœ¨ì— ë”°ë¥¸ ì„±ëŠ¥ ë³€í™”. ëª¨ë¸ ì„±ëŠ¥ì´ synthetic data ë¹„ìœ¨ì— ë‹¨ì¡°ì¦ê°€. 910ê°œ unique protein Ã— í‰ê·  640 ligands = 582,065 í•©ì„± êµ¬ì¡° (ìŠ¤ì¼€ì¼ë§ ì‹¤í—˜ìš©). Flagship ëª¨ë¸ì€ ë” í° ë°ì´í„°ì…‹ ì‚¬ìš©. ì¶œì²˜: ì› ë…¼ë¬¸_

í•µì‹¬ ì¸ì‚¬ì´íŠ¸: AF3ê°€ AF2ì˜ IPAë¥¼ ë²”ìš© Transformerë¡œ ëŒ€ì²´í•˜ë©´ì„œ **inductive biasê°€ ì‚¬ë¼ì¡Œê¸° ë•Œë¬¸ì—**, ë°ì´í„°ë¡œ ì´ë¥¼ ë³´ìƒí•´ì•¼ í•œë‹¤. Pearlì€ synthetic dataë¥¼ í†µí•´ **PDBì— ì¡´ì¬í•˜ì§€ ì•ŠëŠ” í™”í•™ì  ë‹¤ì–‘ì„±**ì„ ëª¨ë¸ì— ë…¸ì¶œì‹œí‚¨ë‹¤.

### Multi-Chain Templating: Drug Discoveryë¥¼ ìœ„í•œ Controllability

Pearlì˜ í…œí”Œë¦¿ ì‹œìŠ¤í…œì€ AF3ì˜ protein-only templateë¥¼ **non-polymeric ì„±ë¶„(ligand, cofactor)**ê¹Œì§€ í™•ì¥í•œë‹¤.

ë‘ ê°€ì§€ inference ëª¨ë“œ:

| Mode | Input | Use Case |
|---|---|---|
| **Unconditional** | Protein sequence + Ligand topology | ìƒˆë¡œìš´ íƒ€ê²Ÿ, ì•Œë ¤ì§„ pocket ì—†ìŒ |
| **Conditional** | + Known apo/holo structure or pocket | Hit-to-lead, lead optimization |

Conditional ëª¨ë“œì—ì„œëŠ” ê¸°ì¡´ì˜ ligand-bound êµ¬ì¡°ë¥¼ "holo-like pocket environment"ë¡œ ì œê³µí•˜ì—¬, ìœ ì‚¬í•œ ligandì˜ í¬ì¦ˆë¥¼ ë” ì •í™•í•˜ê²Œ ì˜ˆì¸¡í•œë‹¤. ì¶”ê°€ë¡œ **guidance/steering ê¸°ë²•**ìœ¼ë¡œ denoising trajectoryì— íŠ¹ì • ë¬¼ë¦¬ì  ì œì•½ì„ ê°•ì œí•  ìˆ˜ ìˆë‹¤.

### Training Recipe

Pearlì€ **5ë‹¨ê³„ curriculum training**ì„ ì‚¬ìš©í•œë‹¤:

1. **ì´ˆê¸° ë‹¨ê³„**: ì‘ì€ crop size, ë‹¨ìˆœí•œ ë°ì´í„° (non-templated PDB, monomer distillation)
2. **ì¤‘ê°„ ë‹¨ê³„**: Template ì •ë³´ ì ì§„ì  ë„ì…
3. **í›„ê¸° ë‹¨ê³„**: Synthetic data ë¹„ìœ¨ ì¦ê°€, ë³µì¡í•œ êµ¬ì¡°ì  prior í¬í•¨

Mixed-precision ì „ëµ:
- **bfloat16**: Trunk ì—°ì‚° (triangle ops, LayerNorm) â€” 22% ì†ë„ í–¥ìƒ, 11% ë©”ëª¨ë¦¬ ì ˆê°
- **float32**: Loss ê³„ì‚°, ì¢Œí‘œ projection, softmax â€” ìˆ˜ì¹˜ ì•ˆì •ì„± ë³´ì¥

NVIDIA cuEquivariance ì»¤ë„ë¡œ ì¶”ê°€ ê°€ì†: í•™ìŠµ 15% ì†ë„ í–¥ìƒ, ì¶”ë¡  10~80% í–¥ìƒ (ê¸´ ì…ë ¥ì¼ìˆ˜ë¡ íš¨ê³¼ í¼).

## Results

### Unconditional Cofolding (Public Benchmarks)

![Main Results](/assets/img/posts/pearl-foundation-model-placing-every-atom/fig3_main_results.png)
_Figure 3: Public ë²¤ì¹˜ë§ˆí¬ì—ì„œì˜ unconditional cofolding ê²°ê³¼. Runs N' Poses, PoseBusters, InternalXtals. Best@5 protocol. ì¶œì²˜: ì› ë…¼ë¬¸_

| Model | RnP (RMSD<2Ã… & PB-valid) | PoseBusters (RMSD<2Ã… & PB-valid) | RnP (RMSD<1Ã… & PB-valid) |
|---|---|---|---|
| AlphaFold 3 | 74.4% | 60.4%* | 61.5% |
| Boltz-1x | 74.3% | 74.2% | 56.5% |
| Boltz-1 | 58.4% | 54.5% | 43.8% |
| Chai-1 | 69.9% | 68.7% | 56.3% |
| ProteniX | 63.0% | â€” | 49.1% |
| **Pearl** | **85.2%** | **84.7%** | **70.0%** |

(*AF3: max confidence from 25 samples, ë‚˜ë¨¸ì§€ëŠ” best@5)

Pearlì˜ ë‘ë“œëŸ¬ì§„ íŠ¹ì§•: **PB-valid ì²´í¬ë¥¼ ì ìš©í•´ë„ ì„±ê³µë¥ ì´ ê±°ì˜ ë–¨ì–´ì§€ì§€ ì•ŠëŠ”ë‹¤** (RnPì—ì„œ 0.7% drop, PoseBustersì—ì„œ 0.4% drop). ì´ëŠ” Pearlì´ ê±°ì˜ ëª¨ë“  í¬ì¦ˆë¥¼ ë¬¼ë¦¬ì ìœ¼ë¡œ íƒ€ë‹¹í•˜ê²Œ ìƒì„±í•œë‹¤ëŠ” ì˜ë¯¸ë‹¤.

### Generalization

![Generalization](/assets/img/posts/pearl-foundation-model-placing-every-atom/fig4_generalization.png)
_Figure 4: Training setê³¼ì˜ ìœ ì‚¬ë„ì— ë”°ë¥¸ ì„±ëŠ¥ ë¶„ì„. ë‚®ì€ ìœ ì‚¬ë„ êµ¬ê°„ì—ì„œë„ Pearlì´ ì¼ê´€ë˜ê²Œ ìš°ìˆ˜. ì¶œì²˜: ì› ë…¼ë¬¸_

Pearlì€ **novel pocket** (ìœ ì‚¬ë„ < 0.2), **novel ligand** (ë¹ˆë„ = 0), **dissimilar chemotype** (Tanimoto < 0.2) ëª¨ë“  ì¶•ì—ì„œ ë‹¤ë¥¸ ëª¨ë¸ì„ ë¦¬ë“œí•œë‹¤. ì´ëŠ” Pearlì´ memorizationì´ ì•„ë‹Œ transferable ruleì„ í•™ìŠµí–ˆìŒì„ ì‹œì‚¬í•œë‹¤.

### Conditional Cofolding

![Conditional Results](/assets/img/posts/pearl-foundation-model-placing-every-atom/fig5_conditional_results.png)
_Figure 5: Conditional cofolding ê²°ê³¼. Structural priorë¥¼ ì œê³µí–ˆì„ ë•Œ ëª¨ë“  ëª¨ë¸ì´ ê°œì„ ë˜ì§€ë§Œ, Pearlì˜ ìš°ìœ„ê°€ ìœ ì§€ë¨. ì¶œì²˜: ì› ë…¼ë¬¸_

**InternalXtals** (challenging real-world drug targets)ì—ì„œì˜ conditional ê²°ê³¼ê°€ íŠ¹íˆ ì¸ìƒì :

| Metric | Pearl | Boltz-1x | Boltz-2â€  |
|---|---|---|---|
| RMSD < 2Ã… & PB-valid | **73.9%** | 51.5% | 41.2% |
| RMSD < 1Ã… & PB-valid | **39.8%** | 10.6% | 18.1% |

(â€ Boltz-2ëŠ” 2023-06-01ê¹Œì§€ì˜ ë°ì´í„°ë¡œ í•™ìŠµ â€” ì§ì ‘ ë¹„êµ ì£¼ì˜)

RMSD < 1Ã…ì—ì„œ Pearlì€ Boltz-1x ëŒ€ë¹„ **~4ë°°** ì„±ëŠ¥ í–¥ìƒ.

### ì™œ RMSD < 1Ã…ê°€ ì¤‘ìš”í•œê°€

![Case Studies](/assets/img/posts/pearl-foundation-model-placing-every-atom/fig8_case_studies.png)
_Figure 8: Pearlì˜ ì„±ê³µê³¼ ì‹¤íŒ¨ ì‚¬ë¡€ ë¶„ì„. Green: training set ì˜ˆì‹œ, Pink: Pearl, Blue: Boltz-2. ì¶œì²˜: ì› ë…¼ë¬¸_

ë…¼ë¬¸ì€ RMSD < 2Ã…ë¥¼ ë§Œì¡±í•˜ëŠ” í¬ì¦ˆì—ë„ **ring flip, í•µì‹¬ interaction ëˆ„ë½, ë¯¸ì„¸í•œ translation** ë“±ì˜ ì˜¤ë¥˜ê°€ ìˆì–´ ì‹¤ì œ drug discoveryì—ì„œëŠ” ì‚¬ìš© ë¶ˆê°€ëŠ¥í•œ ê²½ìš°ê°€ ë§ìŒì„ ê°•ì¡°í•œë‹¤. ì˜ˆë¥¼ ë“¤ì–´:
- Pyrazole ringì´ ë’¤ì§‘í˜€ Val116ê³¼ì˜ í•µì‹¬ ìƒí˜¸ì‘ìš©ì„ ë†“ì¹˜ëŠ” ê²½ìš° (RMSD 1.99Ã…)
- Phenol flipìœ¼ë¡œ Ser87/Met120 ìƒí˜¸ì‘ìš©ì´ ê¹¨ì§€ëŠ” ê²½ìš° (RMSD 1.70Ã…)

ë”°ë¼ì„œ RMSD < 1Ã… + PB-validê°€ medicinal chemistryì—ì„œ ì‹¤ì œë¡œ ìœ ìš©í•œ ê¸°ì¤€ì´ë©°, ì´ ê¸°ì¤€ì—ì„œ Pearlì˜ ìš°ìœ„ê°€ ê°€ì¥ ë‘ë“œëŸ¬ì§„ë‹¤.

## Discussion

### ì €ìê°€ ë°íŒ í•œê³„

- **OOD ì¼ë°˜í™”**: ì—¬ì „íˆ out-of-distribution ë°ì´í„°ì—ì„œ ì •í™•ë„ê°€ í•˜ë½. íŠ¹íˆ ëŒ€ê·œëª¨ induced-fit ë³€í™” ì˜ˆì¸¡ì´ ì–´ë ¤ì›€.
- **Memorization ì”ì¡´**: Synthetic dataê°€ ì™„í™”í•˜ì§€ë§Œ ì œê±°í•˜ì§€ëŠ” ëª»í•¨ â€” í•™ìŠµ ë°ì´í„°ì— ë§ì´ ë“±ì¥í•˜ëŠ” pocketìœ¼ë¡œ ligandë¥¼ ì˜ëª» ë°°ì¹˜í•˜ëŠ” ê²½í–¥ì´ ì—¬ì „íˆ ì¡´ì¬ (Figure 8D, E).
- **Pose selection**: ê³ í’ˆì§ˆ í¬ì¦ˆë¥¼ **ìƒì„±**í•˜ëŠ” ê²ƒì€ ì˜í•˜ì§€ë§Œ (ë†’ì€ best@k), ê°€ì¥ ì¢‹ì€ í¬ì¦ˆë¥¼ **ì„ íƒ**í•˜ëŠ” confidence modelì´ ì—¬ì „íˆ ë¯¸í¡ â€” top-ranked poseê°€ random sampleë³´ë‹¤ ë‚˜ì„ ê²Œ ì—†ëŠ” ê²½ìš°ê°€ ë§ë‹¤.
- **ë¹„ê³µê°œ ëª¨ë¸**: ì½”ë“œ ë¯¸ê³µê°œ, ìƒìš© ëª¨ë¸.

### ì¬í˜„ì„±

- **ì½”ë“œ ê³µê°œ**: âŒ (ìƒìš© ëª¨ë¸, Genesis Molecular AI)
- **í•™ìŠµ ë°ì´í„°**: PDB (ê³µê°œ) + synthetic (ë¹„ê³µê°œ pipeline) + ë‚´ë¶€ ë°ì´í„°
- **í•„ìš” GPU**: NVIDIA H100/H200 í´ëŸ¬ìŠ¤í„°, cuEquivariance v0.6.0
- **ì¬í˜„ ë‚œì´ë„**: â­â­â­â­â­ (ë¶ˆê°€ëŠ¥ â€” ë¹„ê³µê°œ ëª¨ë¸, ë¹„ê³µê°œ synthetic data pipeline)

> ê°™ì€ ë‚  ë¦¬ë·°í•œ [SimpleFold](/posts/simplefold-folding-proteins-simpler/)ì™€ [SeedFold](/posts/seedfold-scaling-biomolecular-structure-prediction/)ê°€ protein foldingì— ì§‘ì¤‘í•œ ë°˜ë©´, Pearlì€ **protein-ligand cofolding**ì´ë¼ëŠ” drug discoveryì— ì§ê²°ë˜ëŠ” ë¬¸ì œì— ì§‘ì¤‘í•œë‹¤. ì„¸ ë…¼ë¬¸ ëª¨ë‘ AlphaFold ê³„ì—´ì„ ë„˜ì–´ì„œëŠ” ë° ì„±ê³µí–ˆì§€ë§Œ, ê°ê° ë‹¤ë¥¸ ì¶•(ì•„í‚¤í…ì²˜ ë‹¨ìˆœí™” / ìŠ¤ì¼€ì¼ë§ / equivariance + synthetic data)ì—ì„œ ì ‘ê·¼í–ˆë‹¤.
{: .prompt-info }

## TL;DR

- **Pearlì€ protein-ligand cofolding SOTA**: Runs N' Posesì—ì„œ RMSD < 2Ã… & PB-valid ê¸°ì¤€ **85.2%** (AlphaFold 3 ëŒ€ë¹„ 14.5% ìƒëŒ€ ê°œì„ ).
- **ì„¸ ê°€ì§€ í•µì‹¬ í˜ì‹ **: (1) Physics-based synthetic data â†’ ì¼ë°˜í™” í–¥ìƒ, (2) SO(3)-equivariant diffusion module â†’ sample efficiency + ë¬¼ë¦¬ì  íƒ€ë‹¹ì„±, (3) Multi-chain templating â†’ controllable inference.
- **ë¬¼ë¦¬ì  íƒ€ë‹¹ì„±**ì´ íŠ¹íˆ ë›°ì–´ë‚¨: PB-valid ì²´í¬ ì ìš© ì‹œ ì„±ê³µë¥  í•˜ë½ì´ 0.4~0.7%ì— ë¶ˆê³¼.
- RMSD < 1Ã… ê°™ì€ **ì—„ê²©í•œ ê¸°ì¤€**ì—ì„œ ì„±ëŠ¥ ê²©ì°¨ê°€ ë” ë²Œì–´ì§ â€” ì‹¤ì œ drug discoveryì— ê°€ì¥ ê´€ë ¨ì„± ë†’ì€ ì§€í‘œ.

## Paper Info

| í•­ëª© | ë‚´ìš© |
|---|---|
| **Title** | Pearl: A Foundation Model for Placing Every Atom in the Right Location |
| **Authors** | Genesis Research Team (Alejandro Doblesâ€ , Nina Jovicâ€ , Kenneth Leidalâ€  et al.) |
| **Affiliations** | Genesis Molecular AI, NVIDIA |
| **Venue** | arXiv preprint (Oct 2025) |
| **Paper** | [arXiv](https://arxiv.org/abs/2510.24670) |
| **Code** | ë¯¸ê³µê°œ (ìƒìš©) |

---

> ì´ ê¸€ì€ LLM(Large Language Model)ì˜ ë„ì›€ì„ ë°›ì•„ ì‘ì„±ë˜ì—ˆìŠµë‹ˆë‹¤. 
> ë…¼ë¬¸ì˜ ë‚´ìš©ì„ ê¸°ë°˜ìœ¼ë¡œ ì‘ì„±ë˜ì—ˆìœ¼ë‚˜, ë¶€ì •í™•í•œ ë‚´ìš©ì´ ìˆì„ ìˆ˜ ìˆìŠµë‹ˆë‹¤.
> ì˜¤ë¥˜ ì§€ì ì´ë‚˜ í”¼ë“œë°±ì€ ì–¸ì œë“  í™˜ì˜í•©ë‹ˆë‹¤.
{: .prompt-info }
